Search
01/03/2024
Preserflo™ MicroShunt implantation combined with Ologen™ in primary and secondary glaucoma patients in a clinical setting
Rojo-Arnao, M, Martinez-de-la-Casa, JM, Albis-Donado, O, Yañez-Castro, G, Maroto-Cejudo, R, Tellez, J, Menoyo-Calatayud, R. Preserflo™ MicroShunt implantation combined with Ologen™ in primary and secondary glaucoma patients in a clinical setting. INDIAN JOURNAL OF OPHTHALMOLOGY. 2024; 72(3)DOI:10.4103/IJO.IJO_1502_23. PMID:38153975. IF:1.800(Q3/6D).
01/03/2024
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis
Martinez-Molina, C, Diaz-Torne, C, Park, HS, Feliu, A, Vidal, S, Corominas, H. Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina-Lithuania. 2024; 60(3)DOI:10.3390/medicina60030360. PMID:38541086. IF:2.400(Q1/3D).
01/03/2024
Design of a panel of indicators for antibiotic stewardship programs in the Emergency Department
Ruiz-Ramos, J, Santolaya-Perrín, MR, González-del-Castillo, J, Candel, FJ, Martín-Quirós, A, López-Contreras-González, J, Julián-Jiménez, A, Suárez-Lledó-Grande, A. Design of a panel of indicators for antibiotic stewardship programs in the Emergency Department. Farmacia Hospitalaria. 2024; 48(2)DOI:10.1016/j.farma.2023.11.006. PMID:38148256. IF:(Q/D).
01/03/2024
Identifying potential predictable indicators for the management of tertiary hospitals
Cossio-Gil, Y, Pérez-Sádaba, FJ, Ribera, J, Giménez, E, Marte, L, Ramos, R, Aurin, E, Peterlunger, M, Steinbrink, J, Bottinelli, EAM, Nelson, N, Seveke, L, Garin, N, Velasco, C. Identifying potential predictable indicators for the management of tertiary hospitals. INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT. 2024; 39(2)DOI:10.1002/hpm.3710. PMID:37910590. IF:1.800(Q3/6D).
01/03/2024
Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis
Melé-Ninot, G, Curto-Barredo, L, Bonfill-Orti, M, Expósito-Serrano, V, Munera-Campos, M, Nart, IF, Loughlin, CRM, Gómez-Armayones, S, Spertino, J, Serra-Baldrich, E. Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2024; 65(2)DOI:10.1111/ajd.14196. PMID:38058123. IF:1.800(Q3/6D).
01/03/2024
Comparative Treatment of Mucocutaneous Lesions in Hereditary Haemorrhagic Telangiectasia Patients With Dual Sequential Pulsed Dye Laser and Neodymium: Yttrium-Aluminium-Garnet Versus Neodymium: Yttrium-Aluminium-Garnet Laser Alone: A Double-Blind Randomized Controlled Study With Quality-of-Life Evaluation
Cubiro, X, Garcia-Melendo, C, Morales-Munera, CE, Riera-Mestre, A, Torres-Iglesias, R, Villanueva, B, Puig, L, Baselga, E. Comparative Treatment of Mucocutaneous Lesions in Hereditary Haemorrhagic Telangiectasia Patients With Dual Sequential Pulsed Dye Laser and Neodymium: Yttrium-Aluminium-Garnet Versus Neodymium: Yttrium-Aluminium-Garnet Laser Alone: A Double-Blind Randomized Controlled Study With Quality-of-Life Evaluation. Actas Dermo-Sifiliograficas. 2024; 115(3)DOI:10.1016/j.ad.2024.01.003. PMID:38185205. IF:(Q/D).